Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

FDA clears single-use, fully disposable endovascular robotic system
The new Liberty System allows users to remotely deliver and manipulate guidewires and catheters during peripheral endovascular procedures.
New York cardiologist headed to prison—DOJ says he paid for referrals, performed unneeded procedures
"Today’s sentence sends a deterrent message to doctors and the healthcare industry," according to a DOJ statement. "If you abuse patient trust for profit, you will face justice."
Abbott’s dissolving stent picks up a key approval
It's another big victory for Abbott's bioresorbable stent for BTK PAD.
FDA announces new recall of self-expanding stents due to risk of ‘serious harm’
The Class I recall includes more than 26,000 vascular stents from Boston Scientific. These devices have been linked to a risk of potential resistance when the stent delivery system is being withdrawn.
Cardiovascular device approvals continue to lead the FDA's Breakthrough Device Program
Cardiology is number one in FDA Breakthrough Device designations at 218, the highest number out of all other clinical categories. This includes 16 new devices cleared in the past year.

stroke brain dementia alzheimer's puzzle mental health

Delirium after TAVR: A common side effect linked to increased mortality

Temporary changes in cognition, including disorganized thinking, are seen in a significant number of patients following transcatheter aortic valve replacement.

Statin use after a bleeding stroke linked to key risk reductions

The study’s authors examined data from more than 15,000 patients who had their first intracerebral hemorrhage from January 2003 to December 2021

Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.

Texas researchers receive $1.14M to develop first CVD drug of its kind

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs.

device implantation during left atrial appendage occlusion (LAAO) procedures

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

Abiomed recalls heart pump catheter labeling after 12 injuries

This is a Class I recall, which means using the devices “may cause serious injuries or death.” The catheter's instructions have been updated to reduce the risk of complications going forward.

How the 2022 contrast media shortage impacted stroke care

A team of specialists tracked CT utilization before, during and after the 2022 shortage, sharing its findings in the American Journal of Neuroradiology.

Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary.

Vascular & Endovascular

FDA clears single-use, fully disposable endovascular robotic system

New York cardiologist headed to prison—DOJ says he paid for referrals, performed unneeded procedures

Abbott’s dissolving stent picks up a key approval

FDA announces new recall of self-expanding stents due to risk of ‘serious harm’

Cardiovascular device approvals continue to lead the FDA's Breakthrough Device Program